Major $32M Settlement in Healthcare Reverse FCA Case - A Compliance Wake-Up Call
The Department of Justice (DOJ) has announced a significant $32 million settlement in a case centered around the reverse false claims provision of the False Claims Act (FCA). The allegations involved a healthcare provider and its executives who knowingly failed to return Medicare overpayments from 2021. This case highlights the DOJ's ongoing efforts to enforce reverse FCA provisions related to overpayment retention. Notably, the defendant had previously entered into a Corporate Integrity Agreement due to an earlier FCA settlement.
This settlement coincides with impending changes from the Centers for Medicare & Medicaid Services (CMS), which plans to revise the Medicare overpayment rule effective January 1, 2025. The amendment will explicitly define when an overpayment is considered "identified" concerning the 60-day reporting and return mandate. By replacing the vague "reasonable diligence" standard, the regulation aims to strengthen providers' obligations to promptly address and report Medicare overpayments, intensifying regulatory compliance requirements.
The reverse false claims liability under the FCA statute targets entities that knowingly conceal or avoid obligations involving monetary transfers to the government. When a provider retains an identified overpayment beyond the statutory timeline, it constitutes a violation of this provision. The Affordable Care Act mandates that healthcare providers report and return Medicare or Medicaid overpayments within 60 days of identification, failing which they face potential FCA liability, including civil monetary penalties and exclusion from federal programs.
Before 2021, CMS's definition of "identification" required providers to engage in "reasonable diligence" in uncovering overpayments. However, after legal challenges, CMS revised its standards. Now, an overpayment is deemed identified when a provider knowingly retains it, aligning with FCA’s knowledge provisions, which define "knowingly" as possessing actual knowledge or recklessly disregarding potential overpayments.
The regulation permits a limited suspension of the 60-day deadline to report and return overpayments if a good-faith investigation is underway. This suspension cannot exceed 180 days from overpayment identification. Providers must thoroughly document any investigations that justify delaying the deadline, underscoring the importance of robust documentation for regulatory compliance.
Finally, this settlement reinforces the government's commitment to using the reverse FCA to recoup improperly retained overpayments. As the DOJ and the Office of Inspector General continue their enforcement efforts, healthcare providers are advised to maintain comprehensive records to demonstrate awareness of overpayments, ensuring preparedness for compliance scrutiny.